Trials / Conditions / Uveitis, Posterior

Uveitis, Posterior

24 registered clinical trials studyying Uveitis, Posterior — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated Wit NCT07423442	Nantes University Hospital	—
Not Yet Recruiting	Role of OCT & OCT Angiography in Patients With Posterior at the Uveitis Clinic of Assiut University Hospital. NCT06743906	Assiut University	—
Active Not Recruiting	A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis NCT06431373	Priovant Therapeutics, Inc.	Phase 3
Recruiting	The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting th NCT05486468	Texas Retina Associates	Phase 3
Active Not Recruiting	Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segme NCT05322070	Alimera Sciences	Phase 4
Unknown	Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study NCT06085079	Massachusetts Eye Research and Surgery Institution	Phase 4
Withdrawn	Ozurdex Monotherapy Trial NCT05101928	Ottawa Hospital Research Institute	Phase 4
Terminated	Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert NCT05070728	EyePoint Pharmaceuticals, Inc.	Phase 3
Withdrawn	Safety &Efficacy of CF101 to Subjects With Uveitis NCT01905124	Can-Fite BioPharma	Phase 2
Terminated	Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) NCT03656692	Mallinckrodt	Phase 4
Completed	MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 NCT02952001	Clearside Biomedical, Inc.	—
Completed	Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant NCT03145025	Bausch & Lomb Incorporated	—
Completed	Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis NCT03097315	Clearside Biomedical, Inc.	Phase 3
Unknown	Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis NCT03066869	Ocular Immunology and Uveitis Foundation	Phase 4
Completed	Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis NCT02595398	Clearside Biomedical, Inc.	Phase 3
Completed	Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uv NCT02255032	Clearside Biomedical, Inc.	Phase 2
Terminated	Safety and Preliminary Efficacy Study of V404 PDS in Uveitis NCT02125266	Forsight Vision4	Phase 1 / Phase 2
Completed	High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients NCT03598452	Aier School of Ophthalmology, Central South University	N/A
Completed	Study of the Effectiveness of Ozurdex for the Control of Uveitis NCT02049476	Johns Hopkins University	Phase 4
Completed	A Long-Term Safety Study of OZURDEX® in Clinical Practice NCT01539577	Allergan	—
Completed	A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Poster NCT00404612	Lux Biosciences, Inc.	Phase 3
Completed	A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or NCT00404742	Lux Biosciences, Inc.	Phase 3
Completed	Prophylactic Anecortave Acetate in Patients With a Retisert Implant NCT00570479	Texas Retina Associates	Phase 1
Completed	Research Study in Patients With Persistent Macular Edema NCT00035906	Allergan	Phase 2